FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082280 [Registered on: 13/03/2025] Trial Registered Prospectively
Last Modified On: 12/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparitive study of effect of intravenous magnesium sulphate versus epidural magnesium sulphate in patients undergoing gynecological oncologic surgeries  
Scientific Title of Study   A prospective comparative study of effect of intravenous magnesium sulphate versus epidural magnesium sulphate on postoperative pain in patients undergoing laparoscopic gynecological oncologic surgeries  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Amrutha Arnepalli 
Designation  Post graduate resident  
Affiliation  Kidwai memorial institute of oncology 
Address  Kidwai memorial institute of oncology, Room no 105, Operation theatre complex ,Department of Anesthesiology and Pain Relief, Dr M H Marigowda road ,Bangalore 560029

Bangalore
KARNATAKA
560029
India 
Phone  8341295050  
Fax    
Email  amrutha2807@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR RASHMI N R  
Designation  Associate Professor 
Affiliation  Kidwai memorial institute of oncology 
Address  Kidwai Memorial Institute of Oncology, Room no 105, Operation theatre complex ,Department of Anesthesiology and Pain Relief, Dr M H Marigowda road ,Bangalore 560029

Bangalore
KARNATAKA
560029
India 
Phone  8792406774  
Fax    
Email  drrashmisatheesh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR RASHMI N R  
Designation  Associate Professor 
Affiliation  Kidwai memorial institute of oncology 
Address  Kidwai Memorial Institute of Oncology, Room no 105, Operation theatre complex ,Department of Anesthesiology and Pain Relief, Dr M H Marigowda road ,Bangalore 560029

Bangalore
KARNATAKA
560029
India 
Phone  8792406774  
Fax    
Email  drrashmisatheesh@gmail.com  
 
Source of Monetary or Material Support  
Kidwai Memorial Institute of Oncology, Room no 105, Operation theatre complex ,Department of Anesthesiology and Pain Relief, Dr M H Marigowda road ,Bangalore 560029 
 
Primary Sponsor  
Name  Dr Amrutha Arnepalli  
Address  Room number 9 ,Post graduate women hostel, kidwai memorial institute of oncology , Hombegowda nagar, Bengaluru ,Karnataka (state)- 560029  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AMRUTHA ARNEPALLI  Kidwai memorial institute of oncology  Room no 105, Operation theatre complex ,Department of Anesthesiology and Pain Relief, Dr M H Marigowda road Bangalore 560029
Bangalore
KARNATAKA 
8341295050

amrutha2807@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MEDICAL ETHICS COMMITTEE, KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C569||Malignant neoplasm of unspecifiedovary, (2) ICD-10 Condition: C51-C58||Malignant neoplasms of female genital organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Epidural Magnesium sulphate  Epidural Bolus of 10ml of diluted Magnesium sulphate 50mg/kg prior to induction followed by 20mg/kg infusion epidurally after creation of pneumoperitoneum 
Comparator Agent  Intravenous Magnesium sulphate  Intravenous Bolus of Magnesium sulphate 50mg/kg body weight prior to induction followed by 20mg/kg infusion after creation of pneumoperitoneum 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1. Patients consenting for study
2. Patients having normal range of Serum magnesium levels.
3. ASA I and II patients
4. Female patients aged between 18-65 years  
 
ExclusionCriteria 
Details  1. Patients who refuse epidural anaesthesia
2. Patients allergic to magnesium sulphate
3. Patients with known neuro muscular diseases, atrio ventricular conduction disturbances
4. Patients receiving treatment with calcium channel blockers or magnesium. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare post operative pain using Visual Analogue Scale in both the study groups.  24 Hours 
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare requirement of post operative rescue analgesia, intra operative muscle relaxants, intra operative haemodynamic parameters in both the study groups   24 hours 
 
Target Sample Size   Total Sample Size="106"
Sample Size from India="106" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a prospective comparitive study of effect of intravenous magnesium sulphate over epidural magnesium sulphate in patients undergoing laparoscopic gynaecological oncological surgeries. Intravenous magnesium sulphate could be used as an alternativeto epidural as it requires less equipment , less cost and less tedious process. Group A patients will receive bolus of 10ml of 50mg/kg diluted form of intravenous magnesium sulphate prior to induction and will be started on 20mg/kg/hr magnesium sulphate intravenous infusion at the start of pneumoperitoneum. Group B will recieve bolus of 10 ml of 50mg/kg diluted form of magnesium sulphate epidurally and will be started on infusion of 20mg/kg/hr magnesium sulphate epidurally at the start of pneumoperitoneum and these infusions shall be continued till the end of surgery. Intraoperative haemodynamic parameters like heart rate, systolic and diastolic blood pressure, saturation, end tidal carbon dioxide levels, and first requirement of muscle relaxant will be recorded at the baseline,at time of study drug, intervals of 5min, 10min,15min, 30min intervals till end of procedure. Post operative pain scale using VAS score, requirement of rescue analgesic will be recorded immediatly after intubation, 30 min after intubation, hourly intervals till first 6 hours, 2hourly till 12hrs post procedure, and 24th hourly.






 
Close